Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment.
Publication
, Journal Article
Shah, SH; de Lemos, JA
Published in: JAMA
July 1, 2009
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
July 1, 2009
Volume
302
Issue
1
Start / End Page
92 / 93
Location
United States
Related Subject Headings
- Risk Assessment
- Humans
- General & Internal Medicine
- Cardiovascular Diseases
- C-Reactive Protein
- Biomarkers
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Shah, S. H., & de Lemos, J. A. (2009). Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment. JAMA, 302(1), 92–93. https://doi.org/10.1001/jama.2009.949
Shah, Svati H., and James A. de Lemos. “Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment.” JAMA 302, no. 1 (July 1, 2009): 92–93. https://doi.org/10.1001/jama.2009.949.
Shah SH, de Lemos JA. Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment. JAMA. 2009 Jul 1;302(1):92–3.
Shah, Svati H., and James A. de Lemos. “Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment.” JAMA, vol. 302, no. 1, July 2009, pp. 92–93. Pubmed, doi:10.1001/jama.2009.949.
Shah SH, de Lemos JA. Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment. JAMA. 2009 Jul 1;302(1):92–93.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
July 1, 2009
Volume
302
Issue
1
Start / End Page
92 / 93
Location
United States
Related Subject Headings
- Risk Assessment
- Humans
- General & Internal Medicine
- Cardiovascular Diseases
- C-Reactive Protein
- Biomarkers
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences